Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported by investigators rather than by patients. There is increasing interest to collect symptomatic AE data via patient-reported outcome (PRO) questionnaires, but it is unclear whether it is feasible to i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Oncol
Hauptverfasser: Basch, Ethan, Dueck, Amylou C., Rogak, Lauren J., Minasian, Lori M., Kelly, William Kevin, O’Mara, Ann M., Denicoff, Andrea M., Seisler, Drew, Atherton, Pamela J., Paskett, Electra, Carey, Lisa, Dickler, Maura, Heist, Rebecca S., Himelstein, Andrew, Rugo, Hope S., Sikov, William M., Socinski, Mark A., Venook, Alan P., Weckstein, Douglas J., Lake, Diana E., Biggs, David D., Freedman, Rachel A., Kuzma, Charles, Kirshner, Jeffrey J., Schrag, Deborah
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553624/
https://ncbi.nlm.nih.gov/pubmed/28208174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6749
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge